Tolmetino [INN-Spanish] en es it fr

Tolmetino [INN-Spanish] Brand names, Tolmetino [INN-Spanish] Analogs

Tolmetino [INN-Spanish] Brand Names Mixture

  • No information avaliable

Tolmetino [INN-Spanish] Chemical_Formula


Tolmetino [INN-Spanish] RX_link

Tolmetino [INN-Spanish] fda sheet

Tolmetino [INN-Spanish] msds (material safety sheet)

Tolmetino [INN-Spanish] Synthesis Reference

No information avaliable

Tolmetino [INN-Spanish] Molecular Weight

296.2 g/mol

Tolmetino [INN-Spanish] Melting Point

186-189 oC

Tolmetino [INN-Spanish] H2O Solubility

1560 mg/L

Tolmetino [INN-Spanish] State


Tolmetino [INN-Spanish] LogP


Tolmetino [INN-Spanish] Dosage Forms

Ophthalmic solution 1% (drops)

Tolmetino [INN-Spanish] Indication

Ophthalmic solution for the treatment of primay keratoconjunctivitis and recurrent epithelial keratitis due to herpes simplex virus, types 1 and 2.

Tolmetino [INN-Spanish] Pharmacology

Trifluridine is a fluorinated pyrimidine nucleoside with in vitro and in vivo activity against herpes simplex virus, types 1 and 2 and vacciniavirus. Some strains of adenovirus are also inhibited in vitro. Trifluridine is also effective in the treatment of epithelial keratitis that has not responded clinically to the topical administration of idoxuridine or when ocular toxicity or hypersensitivity to idoxuridine has occurred. In a smaller number of patients found to be resistant to topical vidarabine, trifluridine was also effective. Trifluridine interferes with DNA synthesis in cultured mammalian cells. However, its antiviral mechanism of action is not completely known.

Tolmetino [INN-Spanish] Absorption

Systemic absorption of trifluridine following therapeutic dosing with trifluridine ophthalmic appears to be negligible.

Tolmetino [INN-Spanish] side effects and Toxicity

Overdosage by ocular instillation is unlikely because any excess solution should be quickly expelled from the conjunctival sac. Acute overdosage by accidental oral ingestion has not occurred. However, should such ingestion occur, the 75 mg dosage of trifluridine in a 7.5 mL bottle of trifluridine is not likely to produce adverse effects. Single intravenous doses of 1.5 to 30 mg/kg/day in children and adults with neoplastic disease produce reversible bone marrow depression as the only potentially serious toxic effect and only after three to five courses of therapy. The acute oral LD50 in the mouse and rat was 4379 mg/kg or higher.

Tolmetino [INN-Spanish] Patient Information

Tolmetino [INN-Spanish] Organisms Affected

Human herpes virus